Zhantao Cao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Zhantao Cao has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Hanjing Jiang
Department of Cardiology, Xiamen TCM Hospital Affiliated to Fujian University of Traditional Chinese Medicine, Xiamen, China
2 shared publications - Jian Li
Department of Cardiology, Xiamen TCM Hospital Affiliated to Fujian University of Traditional Chinese Medicine, Xiamen, China
2 shared publications - Jingting Chen
Department of Cardiology, Xiamen TCM Hospital Affiliated to Fujian University of Traditional Chinese Medicine, Xiamen, China
2 shared publications - Jun Chen
Department of Cardiology, Xiamen TCM Hospital Affiliated to Fujian University of Traditional Chinese Medicine, Xiamen, China
2 shared publications - Kailin Zheng
Department of Cardiology, Xiamen TCM Hospital Affiliated to Fujian University of Traditional Chinese Medicine, Xiamen, China
2 shared publications - Yunsu Wang
Department of Cardiology, Xiamen TCM Hospital Affiliated to Fujian University of Traditional Chinese Medicine, China
2 shared publications
Latest Publications
- Open Access
- 17 February 2026
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 26 (1)
Efficacy and safety of dual antiplatelet therapy de-escalation in East Asian individuals following percutaneous coronary intervention for acute coronary syndrome: a systematic review and meta-analysis
East Asian patients with acute coronary syndrome (ACS) are more prone to bleeding complications than Western populations under comparable antithrombotic re
- 17 February 2026
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 26 (1)
Open AccessEfficacy and safety of dual antiplatelet therapy de-escalation in East Asian individuals following percutaneous coronary intervention for acute coronary syndrome: a systematic review and meta-analysis
East Asian patients with acute coronary syndrome (ACS) are more prone to bleeding complications than Western populations under comparable antithrombotic re
- Top Cited Papers
- 7 January 2026
- Published by Elsevier in International Journal of Medical Informatics
- Vol. 209, 106267
Association between the platelet to white blood cell ratio and short term mortality in critically ill patients with atherosclerotic cardiovascular disease: A retrospective study and machine learning with external validation
- 7 January 2026
- Published by Elsevier in International Journal of Medical Informatics
- Vol. 209, 106267
Top Cited PapersAssociation between the platelet to white blood cell ratio and short term mortality in critically ill patients with atherosclerotic cardiovascular disease: A retrospective study and machine learning with external validation
- Open Access
- 20 August 2025
- Published by IMR Press in Reviews in Cardiovascular Medicine
- Vol. 26 (8) , 43942
Association Between the Hemoglobin, Albumin, Lymphocyte, and Platelet (HALP) Score and Adverse Outcomes in Critically Ill Patients With Acute Myocardial Infarction: A Retrospective Study and Machine Learning Analysis
Background: The hemoglobin, albumin, lymphocyte, and platelet (HALP) score represents a meaningful predictor in many cardiovascular diseases. However, the predictive utility of this score for the outcome of patients admitted to the intensive care unit (ICU) due to acute myocardial infarction (AMI) has yet to be fully elucidated. Methods: Information from the Medical Information Mart for Intensive Care (MIMIC)-IV v3.1 database was used to analyze the association between the HALP score and 90 days and 365 days all-cause mortality in critically ill patients with AMI. Patients were grouped according to the calculated HALP quartiles. Cox proportional hazards regression analysis and restricted cubic spline (RCS) analysis were performed to assess the association between the HALP score and mortality risk. A recursive algorithm identified the HALP inflection point, thus defining high and low HALP groups for the Kaplan–Meier survival analysis. Subgroup analyses analyzed the robustness across clinical strata. Furthermore, predictive models based on machine learning algorithms that included the HALP score were constructed to estimate 90 days mortality. The performance of the models was evaluated using the area under the receiver operating characteristic curve (AUC). Results: A total of 818 AMI patients were included. The analysis revealed mortality rates of 31% at 90 days and 40% at 365 days. Elevated HALP values were independently linked to a reduced risk of death. In fully adjusted models, patients in the top HALP quartile exhibited significantly lower all-cause mortality at 90 days (hazard ratio (HR) = 0.68; 95% confidence interval (CI): 0.47–0.99; p = 0.047) and 365 days (HR = 0.66; 95% CI: 0.47–0.90; p = 0.011). A nonlinear, inverse “L-shaped” association was observed, with an inflection point identified at a HALP value of 19.41. Below this value, each unit increase in the HALP score reduced mortality risk by 2.4%–2.7%. The Kaplan–Meier curves confirmed an improved survival above the threshold. Meanwhile, the subgroup analyses revealed a generally consistent association between the HALP score and mortality, except for age, where a significant interaction was observed (p = 0.003), indicating a stronger protective effect in older patients. Machine learning analyses supported the robustness and predictive value of the HALP score, with a maximum AUC of 0.7804. Conclusions: The HALP score is significantly associated with all-cause mortality among critically ill individuals suffering from AMI.
- 20 August 2025
- Published by IMR Press in Reviews in Cardiovascular Medicine
- Vol. 26 (8) , 43942
Open AccessAssociation Between the Hemoglobin, Albumin, Lymphocyte, and Platelet (HALP) Score and Adverse Outcomes in Critically Ill Patients With Acute Myocardial Infarction: A Retrospective Study and Machine Learning Analysis
Background: The hemoglobin, albumin, lymphocyte, and platelet (HALP) score represents a meaningful predictor in many cardiovascular diseases. However, the predictive utility of this score for the outcome of patients admitted to the intensive care unit (ICU) due to acute myocardial infarction (AMI) has yet to be fully elucidated. Methods: Information from the Medical Information Mart for Intensive Care (MIMIC)-IV v3.1 database was used to analyze the association between the HALP score and 90 days and 365 days all-cause mortality in critically ill patients with AMI. Patients were grouped according to the calculated HALP quartiles. Cox proportional hazards regression analysis and restricted cubic spline (RCS) analysis were performed to assess the association between the HALP score and mortality risk. A recursive algorithm identified the HALP inflection point, thus defining high and low HALP groups for the Kaplan–Meier survival analysis. Subgroup analyses analyzed the robustness across clinical strata. Furthermore, predictive models based on machine learning algorithms that included the HALP score were constructed to estimate 90 days mortality. The performance of the models was evaluated using the area under the receiver operating characteristic curve (AUC). Results: A total of 818 AMI patients were included. The analysis revealed mortality rates of 31% at 90 days and 40% at 365 days. Elevated HALP values were independently linked to a reduced risk of death. In fully adjusted models, patients in the top HALP quartile exhibited significantly lower all-cause mortality at 90 days (hazard ratio (HR) = 0.68; 95% confidence interval (CI): 0.47–0.99; p = 0.047) and 365 days (HR = 0.66; 95% CI: 0.47–0.90; p = 0.011). A nonlinear, inverse “L-shaped” association was observed, with an inflection point identified at a HALP value of 19.41. Below this value, each unit increase in the HALP score reduced mortality risk by 2.4%–2.7%. The Kaplan–Meier curves confirmed an improved survival above the threshold. Meanwhile, the subgroup analyses revealed a generally consistent association between the HALP score and mortality, except for age, where a significant interaction was observed (p = 0.003), indicating a stronger protective effect in older patients. Machine learning analyses supported the robustness and predictive value of the HALP score, with a maximum AUC of 0.7804. Conclusions: The HALP score is significantly associated with all-cause mortality among critically ill individuals suffering from AMI.